Error: Could not add to watchlist. X
+ Watchlist

IBI Biotechnology *L

IBIBIOL:IT
138.93
ILs
3.25
2.29%
As of 12:59 AM EST 11/30/2016
Fund Type
Open-End Fund
52Wk Range
125.45 - 170.32
1 Yr Return
-17.63%
YTD Return
-17.72%
Previous Close
142.18
52Wk Range
125.45 - 170.32
1 Yr Return
-18.13%
YTD Return
-17.72%
Fund Type
Open-End Fund
Objective
Health Care Sector
Asset Class Focus
Equity
Geographic Focus
Israel
NAV (on 11/30/2016)
138.93
Total Assets (m ILS) (on 10/31/2016)
120.100
Inception Date
07/12/2000
Last Dividend (on -)
-
Dividend Indicated Gross Yield
-
Fund Managers
ODED GAL
Front Load Fee
0.00%
Back Load Fee
-
Redemption Fee
-
12b-1 Fee
-
Current Mgmt Fee
2.50%
Expense Ratio
-

Top Fund Holdings

Name Position Value % of Fund
29.80 k 12.83 m 9.66
56.00 k 12.74 m 9.59
34.00 k 12.33 m 9.29
11.50 k 12.23 m 9.21
7.50 k 11.15 m 8.39
27.00 k 10.91 m 8.22
35.00 k 10.39 m 7.82
13.00 k 9.21 m 6.94
7.00 k 8.10 m 6.10
80.00 k 7.30 m 5.50
Profile
IBI Biotechnology *L is an open-end fund incorporated in Israel. The objective of the Fund is capital appreciation. The Fund will invest at least 90% of its assets in shares of companies principally engaged in various fields of biotechnology.
Address
Israel Brokerage Investments Ltd
9, Ahad H'aam Street
Shalom Tower, 26th Floor
61291, Tel Aviv
Israel
Phone
-